Stay updated on Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The KEYNOTE-189 record for pembrolizumab with pemetrexed/platinum chemotherapy versus chemotherapy alone is displayed, including its study details, eligibility criteria, outcome measures, posted results, and linked study documents.
    Difference
    71%
    Check dated 2026-11-08T14:30:36.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:42:43.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:37:24.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site revision as v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T22:13:16.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer’s site revision number changed from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:05:21.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error indicating restricted access to the study record. Additionally, sponsor-related content and study documents associated with Merck were removed from the page.
    Difference
    22%
    Check dated 2026-09-20T20:47:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page.